Email updates

Keep up to date with the latest news and content from BMC Surgery and BioMed Central.

Open Access Case report

Heterotopic pancreas in excluded stomach diagnosed after gastric bypass surgery

Marta Guimarães1, Pedro Rodrigues1, Gil Gonçalves1, Mário Nora1 and Mariana P Monteiro23*

Author Affiliations

1 Department of General Surgery, Hospital de São Sebastião, Santa Maria da Feira, Portugal

2 Endocrinology Unit of Hospital São Sebastião, Hospital de São Sebastião, Santa Maria da Feira, Portugal

3 Department of Anatomy, Multidisciplinary Unit for Biomedical Research (UMIB), ICBAS, University of Porto, Porto, Portugal

For all author emails, please log on.

BMC Surgery 2013, 13:56  doi:10.1186/1471-2482-13-56

Published: 23 November 2013

Abstract

Background

Heterotopic pancreas is defined as finding of pancreatic tissue without anatomic and vascular continuity with the normal pancreas. Heterotopic pancreas is a rare condition difficult to diagnose and with controversial clinical management.

Case presentation

We describe a 43 year old female patient previously submitted to laparoscopic gastric bypass for primary treatment of morbid obesity; 5 years later, the patient was discovered to have a mass in the antrum of the excluded stomach that was found to be heterotopic pancreatic tissue. Before gastric bypass surgery, the presence of the pancreatic mass in the gastric wall was unnoticed in the imagiologic records.

Conclusion

This is the first reported case of pancreatic heterotopy diagnosed in the excluded stomach after gastric bypass. A putative role of incretin hormones in mediating pancreatic cell hyperplasia of heterotopic pancreatic remnants should be considered an additional hypothesis that requires further research.

Keywords:
Heterotopic pancreas; Gastric bypass; Excluded stomach; Incretins